Lung transplantation for COVID-19 acute respiratory distress syndrome: The British Columbian experience with new disease pathology

Lung transplantation is a life-saving treatment for patients with end-stage lung disease. COVID-19 has been associated with a severe and rapid decline in pulmonary function, in which case lung transplantation has been described to be effective. We herein describe nine patients who underwent lung transplantation for COVID-19 acute respiratory distress syndrome, of whom six were bridged with extracorporeal membrane oxygenation (ECMO). The median time of pre-operative observation periods was 54 days to ensure no lung function recovery and the time to wean off ECMO was 3 days.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: THORACIC – Young Surgeon's Note Source Type: research